Brain Tumor Reports
54

Volume 17 Number 7
July 2017



Home > Publications > Brain Tumor Reports > Volume 17, Year 2017 > Number 7, July


CONTENTS



BRAIN TUMORS
DIFFUSE ASTROCYTIC AND OLIGODENDROGLIAL TUMORS
GLIOBLASTOMA
GLIOMAS
MEDULLOBLASTOMA





BRAIN TUMORS



Fuller CE, Jones DTW, Kieran MW.
New Classification for Central Nervous System Tumors: Implications for Diagnosis and Therapy.
Am Soc Clin Oncol Educ Book. 2017;37:753-763. doi: 10.14694/EDBK_175088. 2017 Jun 3.
Source | Abstract | Full text | Similar articles




Komori T.
The 2016 WHO Classification of Tumours of the Central Nervous System: The Major Points of Revision.
Neurol Med Chir (Tokyo). 2017 Jun 8. doi: 10.2176/nmc.ra.2017-0010. [Epub ahead of print]
Source | Abstract | Full text | Similar articles




Penas-Prado M.
Practice-Changing Abstracts From the 2016 Society for Neuro-Oncology Annual Scientific Meeting.
Am Soc Clin Oncol Educ Book. 2017;37:187-191. doi: 10.14694/EDBK_175563. 2017 Jun 4.
Source | Abstract | Full text | Similar articles





DIFFUSE ASTROCYTIC AND OLIGODENDROGLIAL TUMORS



ANAPLASTIC ASTROCYTOMA


Li ZG, Mu HY.
Extracranial bone metastases from recurrent anaplastic astrocytoma on FDG PET/CT: A case report a care-compliant article.
Medicine (Baltimore). 2017 Jun;96(23):e7123. doi: 10.1097/MD.0000000000007123.
Source | Abstract | Full text | Similar articles





GLIOBLASTOMA



Anjum K, Shagufta BI, Abbas SQ, Patel S, Khan I, Shah SAA, Akhter N, Hassan SSU.
Current status and future therapeutic perspectives of glioblastoma multiforme (GBM) therapy: A review.
Biomed Pharmacother. 2017 Jun 2;92:681-689. doi: 10.1016/j.biopha.2017.05.125. [Epub ahead of print]
Source | Abstract | Full text | Similar articles




Guedes de Castro D, Matiello J, Roa W, Ghosh S, Kepka L, Kumar N, Sinaika V, Lomidze D, Hentati D, Rosenblatt E, Fidarova E.
Survival Outcomes With Short-Course Radiation Therapy in Elderly Patients With Glioblastoma: Data From a Randomized Phase 3 Trial.
Int J Radiat Oncol Biol Phys. 2017 Jul 15;98(4):931-938. doi: 10.1016/j.ijrobp.2017.03.037. Epub 2017 Mar 30.
Source | Abstract | Full text | Similar articles




Harris G, Jayamanne D, Wheeler H, Gzell C, Kastelan M, Schembri G, Brazier D, Cook R, Parkinson J, Khasraw M, Louw S, Back M.
Survival Outcomes of Elderly Patients With Glioblastoma Multiforme in Their 75th Year or Older Treated With Adjuvant Therapy.
Int J Radiat Oncol Biol Phys. 2017 Jul 15;98(4):802-810. doi: 10.1016/j.ijrobp.2017.02.028. Epub 2017 Feb 21.
Source | Abstract | Full text | Similar articles




McDonald JT, Gao X, Steber C, Lee Breed J, Pollock C, Ma L, Hlatky L.
Host mediated inflammatory influence on glioblastoma multiforme recurrence following high-dose ionizing radiation.
PLoS One. 2017 May 22;12(5):e0178155. doi: 10.1371/journal.pone.0178155. eCollection 2017.
Source | Abstract | Full text | Similar articles | Editor's choice




Nakajima H, Furukawa C, Chang YC, Ogata H, Magae J.
Delayed Growth Suppression and Radioresistance Induced by Long-Term Continuous Gamma Irradiation.
Radiat Res. 2017 Jun 9. doi: 10.1667/RR14666.1. [Epub ahead of print]
Source | Abstract | Full text | Similar articles




Penas-Prado M.
Practice-Changing Abstracts From the 2016 Society for Neuro-Oncology Annual Scientific Meeting.
Am Soc Clin Oncol Educ Book. 2017;37:187-191. doi: 10.14694/EDBK_175563.
Source | Abstract | Full text | Similar articles




Peng P, Wei W, Long C, Li J.
Atorvastatin augments temozolomide's efficacy in glioblastoma via prenylation-dependent inhibition of Ras signaling.
Biochem Biophys Res Commun. 2017 Jul 29;489(3):293-298. doi: 10.1016/j.bbrc.2017.05.147. Epub 2017 May 26.
Source | Abstract | Full text | Similar articles




Rigamonti A, Imbesi F, Silvani A, Grimod G, Prone V, Gaviani P, Ardizzoia A, Milanesi I, Arienti V, Agostoni E, Di Meco F, Salmaggi A.
Pattern of care and outcome in elderly patients with glioblastoma: Data in 151 patients from 3 Lombardia Hospitals.
J Neurol Sci. 2017 Jul 15;378:3-8. doi: 10.1016/j.jns.2017.04.030. Epub 2017 Apr 18.
Source | Abstract | Full text | Similar articles




Robin AM, Lee I, Kalkanis SN.
Reoperation for Recurrent Glioblastoma Multiforme.
Neurosurg Clin N Am. 2017 Jul;28(3):407-428. doi: 10.1016/j.nec.2017.02.007.
Source | Abstract | Full text | Similar articles




Sepúlveda-Sánchez JM, Vaz MÁ, Balañá C, Gil-Gil M, Reynés G, Gallego Ó, Martínez-García M, Vicente E, Quindós M, Luque R, Ramos A, Ruano Y, Pérez-Segura P, Benavides M, Sánchez-Gómez P, Hernández-Laín A.
Phase II trial of dacomitinib, a pan-HER (human epidermal growth factor receptor) tyrosine kinase inhibitor, in recurrent glioblastoma patients with EGFR amplification.
Neuro Oncol. 2017 Jun 1. doi: 10.1093/neuonc/nox105. [Epub ahead of print]
Source | Abstract | Full text | Similar articles




Shah AH, Jusué-Torres I, Ivan ME, Komotar RJ, Kasahara N.
Pathogens and glioma: a history of unexpected discoveries ushering in novel therapy.
J Neurosurg. 2017 Jun 9:1-8. doi: 10.3171/2016.12.JNS162123. [Epub ahead of print]
Source | Abstract | Full text | Similar articles




Soheila RD, Alessandro R, Hambra DV, Danilo P, Sabino L, Paola P, Benedetta C, Tempesta D, Coletti G, Cipolloni G, Grazia CM, Renato G.
Stemness Markers Detection In The Periphery Of Glioblastomas And Glioblastoma Ability To Generate Glioma Stem Cells: Clinical Correlations.
World Neurosurg. 2017 May 27. pii: S1878-8750(17)30798-2. doi: 10.1016/j.wneu.2017.05.099. [Epub ahead of print]
Source | Abstract | Full text | Similar articles | Editor's choice




Villanueva-Meyer JE, Han SJ, Cha S, Butowski NA.
Early tumor growth between initial resection and radiotherapy of glioblastoma: incidence and impact on clinical outcomes.
J Neurooncol. 2017 May 31. doi: 10.1007/s11060-017-2511-z. [Epub ahead of print]
Source | Abstract | Full text | Similar articles




Zacharia BE, DiStefano N, Mader MM, Chohan MO, Ogilvie S, Brennan C, Gutin P, Tabar V.
Prior malignancies in patients harboring glioblastoma: an institutional case-study of 2164 patients.
J Neurooncol. 2017 May 27. doi: 10.1007/s11060-017-2512-y. [Epub ahead of print]
Source | Abstract | Full text | Similar articles





GLIOMAS



Rizzo A, Donzelli S, Girgenti V, Sacconi A, Vasco C, Salmaggi A, Blandino G, Maschio M, Ciusani E.
In vitro antineoplastic effects of brivaracetam and lacosamide on human glioma cells.
J Exp Clin Cancer Res. 2017 Jun 6;36(1):76. doi: 10.1186/s13046-017-0546-9.
Source | Abstract | Full text | Similar articles




Uhm JH, Porter AB.
Treatment of Glioma in the 21st Century: An Exciting Decade of Postsurgical Treatment Advances in the Molecular Era.
Mayo Clin Proc. 2017 Jun;92(6):995-1004. doi: 10.1016/j.mayocp.2017.01.010
Source | Abstract | Full text | Similar articles




BRAIN STEM GLIOMAS


Diffuse intrinsic pontine gliomas


Cohen KJ, Jabado N, Grill J.
Diffuse intrinsic pontine gliomas-current management and new biologic insights. Is there a glimmer of hope?
Neuro Oncol. 2017 Mar 24. doi: 10.1093/neuonc/nox021. [Epub ahead of print]
Source | Abstract | Full text | Similar articles




Hashizume R.
Epigenetic Targeted Therapy for Diffuse Intrinsic Pontine Glioma.
Neurol Med Chir (Tokyo). 2017 Jun 7. doi: 10.2176/nmc.ra.2017-0018. [Epub ahead of print]
Source | Abstract | Full text | Similar articles




Kieran MW.
Lessons learned from diffuse intrinsic pontine glioma: how a terrible disease forced us to think better.
Neuro Oncol. 2017 May 24. doi: 10.1093/neuonc/nox022. [Epub ahead of print]
Source | Abstract | Full text | Similar articles




Veldhuijzen van Zanten SEM, Lane A, Heymans MW, Baugh J, Chaney B, Hoffman LM, Doughman R, Jansen MHA, Sanchez E, Vandertop WP, Kaspers GJL, van Vuurden DG, Fouladi M, Jones BV, Leach J.
External validation of the diffuse intrinsic pontine glioma survival prediction model: a collaborative report from the International DIPG Registry and the SIOPE DIPG Registry.
J Neurooncol. 2017 May 30. doi: 10.1007/s11060-017-2514-9. [Epub ahead of print]
Source | Abstract | Full text | Similar articles





MEDULLOBLASTOMA



Bavle A, Parsons DW.
From One to Many: Further Refinement of Medulloblastoma Subtypes Offers Promise for Personalized Therapy.
Cancer Cell. 2017 Jun 12;31(6):727-729. doi: 10.1016/j.ccell.2017.05.013.
Source | Abstract | Full text | Similar articles




Cavalli FMG, Remke M, Rampasek L, Peacock J, Shih DJH, Luu B, Garzia L, Torchia J, Nor C, Morrissy AS, Agnihotri S, Thompson YY, Kuzan-Fischer CM, Farooq H, Isaev K, Daniels C, Cho BK, Kim SK, Wang KC, Lee JY, Grajkowska WA, Perek-Polnik M, Vasiljevic A, Faure-Conter C, Jouvet A, Giannini C, Nageswara Rao AA, Li KKW, Ng HK, Eberhart CG, Pollack IF, Hamilton RL, Gillespie GY, Olson JM, Leary S, Weiss WA, Lach B, Chambless LB, Thompson RC, Cooper MK, Vibhakar R, Hauser P, van Veelen MC, Kros JM, French PJ, Ra YS, Kumabe T, López-Aguilar E, Zitterbart K, Sterba J, Finocchiaro G, Massimino M, Van Meir EG, Osuka S, Shofuda T, Klekner A, Zollo M, Leonard JR, Rubin JB, Jabado N, Albrecht S, Mora J, Van Meter TE, Jung S, Moore AS, Hallahan AR, Chan JA, Tirapelli DPC, Carlotti CG, Fouladi M, Pimentel J, Faria CC, Saad AG, Massimi L, Liau LM, Wheeler H, Nakamura H, Elbabaa SK, Perezpeña-Diazconti M, Chico Ponce de León F, Robinson S, Zapotocky M, Lassaletta A, Huang A, Hawkins CE, Tabori U, Bouffet E, Bartels U, Dirks PB, Rutka JT, Bader GD, Reimand J, Goldenberg A, Ramaswamy V, Taylor MD.
Intertumoral Heterogeneity within Medulloblastoma Subgroups.
Cancer Cell. 2017 Jun 12;31(6):737-754.e6. doi: 10.1016/j.ccell.2017.05.005.
Source | Abstract | Full text | Similar articles




Juhnke BO, Mynarek M, Rutkowski S.
Refining medulloblastoma subgroups.
Lancet Oncol. 2017 May 22. pii: S1470-2045(17)30332-7. doi: 10.1016/S1470-2045(17)30332-7. [Epub ahead of print]
Source | Abstract | Full text | Similar articles




Kieran MW, Chisholm J, Casanova M, Brandes AA, Aerts I, Bouffet E, Bailey S, Leary S, MacDonald TJ, Mechinaud F, Cohen KJ, Riccardi R, Mason W, Hargrave D, Kalambakas S, Deshpande P, Tai F, Hurh E, Geoerger B.
Phase I study of oral sonidegib (LDE225) in pediatric brain and solid tumors and a phase II study in children and adults with relapsed medulloblastoma.
Neuro Oncol. 2017 Jun 9. doi: 10.1093/neuonc/nox109. [Epub ahead of print]
Source | Abstract | Full text | Similar articles




Mahapatra S, Amsbaugh M.
Cancer, Medulloblastoma.
StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2017 Jun-.2017 May 21.
Source | Abstract | Full text | Similar articles




Schwalbe EC, Lindsey JC, Nakjang S, Crosier S, Smith AJ, Hicks D, Rafiee G, Hill RM, Iliasova A, Stone T, Pizer B, Michalski A, Joshi A, Wharton SB, Jacques TS, Bailey S, Williamson D, Clifford SC.
Novel molecular subgroups for clinical classification and outcome prediction in childhood medulloblastoma: a cohort study.
Lancet Oncol. 2017 May 22. pii: S1470-2045(17)30243-7. doi: 10.1016/S1470-2045(17)30243-7. [Epub ahead of print]
Source | Abstract | Full text | Similar articles




Yu J, Zhao R, Shi W, Li H.
Risk factors for the prognosis of pediatric medulloblastoma: a retrospective analysis of 40 cases.
Clinics (Sao Paulo). 2017 May;72(5):294-304. doi: 10.6061/clinics/2017(05)07.
Source | Abstract | Full text | Similar articles